Jump to content

Adventrx gets green light


Recommended Posts

Adventrx gets green light

Adventrx Pharmaceuticals said the Food and Drug Administration accepted its application to begin testing a potential cancer drug. The San Diego drug development company said it would conduct clinical trials to establish that its drug, ANX-530, works the same as Navelbine, an anti-cancer agent approved to fight non-small-cell lung cancer.

Adventrx will begin testing the drug in humans in January. The company said it expected to file an application seeking approval for the drug by the end of 2007.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.